Candel Therapeutics (CADL) Cash from Investing Activities: 2020-2024
Historic Cash from Investing Activities for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to -$16,000.
- Candel Therapeutics' Cash from Investing Activities rose 90.22% to -$27,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$280,000, marking a year-over-year increase of 78.41%. This contributed to the annual value of -$16,000 for FY2024, which is 94.29% up from last year.
- As of FY2024, Candel Therapeutics' Cash from Investing Activities stood at -$16,000, which was up 94.29% from -$280,000 recorded in FY2023.
- In the past 5 years, Candel Therapeutics' Cash from Investing Activities ranged from a high of $38.5 million in FY2020 and a low of -$1.8 million during FY2021.
- For the 3-year period, Candel Therapeutics' Cash from Investing Activities averaged around -$531,000, with its median value being -$280,000 (2023).
- Per our database at Business Quant, Candel Therapeutics' Cash from Investing Activities plummeted by 104.77% in 2021 and then surged by 94.29% in 2024.
- Yearly analysis of 5 years shows Candel Therapeutics' Cash from Investing Activities stood at $38.5 million in 2020, then plummeted by 104.77% to -$1.8 million in 2021, then increased by 29.32% to -$1.3 million in 2022, then soared by 78.41% to -$280,000 in 2023, then spiked by 94.29% to -$16,000 in 2024.